Resource Filter: COMET™
Continuous quantification of HER2 expression by microfluidic precision immunofluorescence estimates HER2 gene amplification in breast cancer
Date
Microfluidic processor allows rapid HER2 immunohistochemistry of breast carcinomas and significantly reduces ambiguous (2+) read-outs
Date
COMET™ Assay Validation
Date
seqIF™ assay development on COMET™
Date
COMET™ The only high-throughput, hyperplex platform
Date
From a tissue to another one: easy adaptation of a core immuno-oncology panel
Date
